Asia Deal Watch: ProGen To Partner With Rani On GLP-2 Agonist In Obesity

Plus deals involving Healios/Astellas Institute for Regenerative Medicine, Otsuka/Ionis, IMBiologics/Navigator and more.

Asia Deal Watch
• Source: Alamy

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker.

Rani Therapeutics Holdings, Inc. said on 24 June that it has agreed with ProGen for the co-development and commercialization...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deal Watch

More from Deals